Human medicines European public assessment report (EPAR): Mavenclad, cladribine, Date of authorisation: 22/08/2017, Revision: 12, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 6 May 2025 - 14:32

Human medicines European public assessment report (EPAR): Mavenclad, cladribine, Date of authorisation: 22/08/2017, Revision: 12, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/mavenclad

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters